ArticleFrontiers in pediatrics2026
Case Report: Prenatal clues and postnatal evolution: a case of williams syndrome diagnosed following progressive cardiovascular phenotypes.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Williams syndrome (WS) is a rare genetic disorder often missed prenatally due to nonspecific presentations. Case presentation: We describe an infant with Williams syndrome diagnosed after progressive cardiovascular changes during infancy. Prenatal ultrasonography showed fetal growth restriction, persistent left superior vena cava (PLSVC), left-right cardiac chamber disproportion (LRCCD), and suspected coarctation of the aorta (CoA). Early postnatal echocardiography revealed mild aortic isthmus hypoplasia without definite supravalvular aortic or pulmonary arterial stenosis. Serial follow-up subsequently demonstrated supravalvular aortic stenosis (SVAS) and right pulmonary artery stenosis by 7 months of age, and chromosomal microarray analysis (CMA) confirmed a 1.42 Mb deletion at 7q11.23. At 5 years and 3 months of age, the child remained clinically stable, with stable SVAS and near resolution of pulmonary arterial stenosis. A retrospective review of nine fetuses with prenatally confirmed 7q11.23 microdeletion showed that prenatal cardiovascular abnormalities were present in 6 cases, mainly involving the aortic and pulmonary arterial systems, often with extracardiac findings such as renal anomalies and fetal growth restriction (FGR). Conclusion: WS may show dynamic cardiovascular evolution from nonspecific prenatal or neonatal findings to characteristic vascular lesions during infancy. Fetal cardiovascular abnormalities combined with FGR or other extracardiac anomalies should raise suspicion for WS and prompt consideration of CMA. Serial postnatal echocardiography may help clarify prenatal clues and facilitate earlier diagnosis and management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.